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Abstract  
Fillers are used for facial sculpturing and anti-ageing treatments with increasing popularity. The optimal outcome 
of any filler treatment depends upon different factors: exact indication, known limitations, filler product, and filler 
placement. For volumizing effect and longevity of procedures, however, the interaction of fillers and facial fat pads 
seems to be crucial. Here, we will review the optimum filler injections for facial applications in relationship to new 
data and concepts concerning facial fat pads anatomy and physiology. Such a view will us enable to provide 
optimum results in aesthetic procedures.   
 
Introduction 
 
The facial ageing process is characterised 
loss of volume and ptosis. This is particularly visible in 
the two lower thirds of the face. Here, bone 
ligamentous structures, muscles, facial fat pads and 
skin contribute to the triangular frontal shape that 
characterises an aged face [1]. 
The current concept in facial rejuvenation is to 
gain a natural youthful appearance by three-
dimensional sculpturing with a minimally invasive 
approach [2, 3]. The major biophysical qualities of 
“dermal” fillers are viscosity, elasticity and cohesivity. 
However, once placed into human tissue, fillers 
remain not inert but interact with cells and tissues [4]. 
 
 
Anatomy of facial fat pads 
 
Facial fat pads can be divided into superficial 
and deep fat pads [5]. Recently another, the third 
compartment has been identified – the deepest facial 
fat compartment including buccal and temporal deep 
fat pads [6]. 
The superficial, subcutaneous adipose layer 
is separated by fibrous septae and consists of dermal 
white adipocytes (dWAT). In the medial and lateral 
face as well as parts of the periorbital region, temple 
and forehead the adherence to the skin are loose 
(Type 1 dWAT). Due to the rich, three-dimensional 
septal network, it can be classified as structural WAT 
[6-8]. 
The type 2 WAT is localised to eyebrows, 
perinasal and perioral region. Here, a tighter 
connection to the skin is realised by direct insertion of 
facial muscles and fibrous septae into the skin. The 
fibrous WAT is sharply demarcated from structural 
WAT in nasolabial, labiomandibular and submental 
sulci [6-8]. 
dWAT is a dynamic structure that is involved 
in the innate immune system, thermoregulation, 
wound healing, and hair follicle cycling. These 
adipocytes have been shown to transdifferentiate into 
myofibroblasts under certain circumstances [9]. 
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Deep fat compartments contain subcutaneous 
white adipose tissue (sWAT) separated by the 
superficial musculoaponeurotic system (SMAS) in the 
midface and the superficial temporal fascia in the 
temple. Boundaries of these deep fat pads are 
created by facial muscles and retaining ligaments. 
The deep fat pads are slowly renewing with an 
average turnover time of about ten years [10]. 
In some parts of the face, another deeper fat 
pad compartment can be found. The most prominent 
are the buccal fat pad localised in the Bucco temporal 
space and serve a metabolic function [11]. 
 
Figure 1: Abdominal subcutaneous fat with small adipocytes in the 
superficial layer and large adipocytes in the deep layer separated 
by a delicate membrane (Arrow) 
 
 
Adipocytes are not uniform by size and 
functionality (Fig. 1). The release of chemokines from 
adipocytes [12] and macrophage infiltration [13] are 
directly related to the size of the adipocytes. 
Hypertrophic (large) adipocytes exhibit increased 
expression and secretion of pro-inflammatory 
cytokines, including tumour necrosis factor α (TNFα), 
interleukin (IL)-6, IL-8, and monocyte chemoattractant 
protein-1 (MCP-1) [14]. This elevation of pro-
inflammatory cytokines leads to serine 
phosphorylation of insulin receptor substrate-1 via 
nuclear factor κB and Jun N-terminal kinase 
signalling, resulting in the development of insulin 
resistance [15]. 
A theoretical model suggests in the 
development of obesity, adipocyte hypertrophy and 
macrophage recruitment becomes a vicious cycle, 
that finally blocks preadipocyte recruitment and overall 
adipose tissue functioning and health [16]. There is 
also some evidence linking adipocyte size and weight 
loss regain [17, 18]. Additionally, Dankel et al. (2014) 
showed that some molecular mechanisms were 
significantly different in small from large adipocytes in 
abdominal fatty tissue. And, this difference allows the 
assumption that small adipocytes are the main source 
for endotrophin and thus control the adipose tissue 
development and expandability [19]. There is a strong 
correlation between BMP4 levels and adipocyte size, 
as well as insulin sensitivity in humans [20]. 
Figure 2: Superficial malar fat pad with larger mature adipocytes 
embedded in a fibrous network representing type 1 sWAT, also 
known as structural facial fat 
  
 
Adipose tissue consists not only of adipocytes 
but extracellular matrix as well. There is an interplay 
between adipocytes and high-molecular weight 
hyaluronic acid (HA; 2000 kDa) of the extracellular 
matrix. HA is responsible for extracellular water 
binding capacity of adipose tissue. Higher water 
content prevents lipolysis by reduction of aquaporin-7 
channels in adipocytes. The application of 
hyaluronidase, on the other side, can reduce fat 
masses and adipocyte size significantly [21, 22]. 
Medium molecular weight HA (50 kDa) 
inhibited differentiation of pre-adipocytes via major 
adipogenic transcription factors PPAR- and C/EBP-. 
Also, FAS and ap2 – two target genes of PPAR- 
were also suppressed [23]. 
Bertossi et al. (2015) classified facial fat using 
transmission and scanning electron microscopy: 
- Malar fat pad with large adipocytes by loose 
and thin collagen fibres (Type 1) (Fig. 2). 
- Labial and nasal fat pads with mature 
adipocytes associated with a dense three-
dimensional extracellular matrix (Type 2) (Fig. 
3). 
- Periorbital fat pads with pronounced lobules 
and dense basket-like extracellular matrix. 
- Buccal fat pad with large mature adipocytes 
not completely covered by extracellular matrix 
fibres [8]. 
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Mechanical stiffness of adipose tissue is 
inversely correlated with the average size of 
adipocytes. The fibrous WAT develops the highest 
stiffness values. During the facial ageing process, 
prominent changes can be macroscopically noted in 
structural WAT. This leads to deformations like ptosis, 
wrinkles and jowls [24]. 
 
 
Facial fat pads and filler placement 
 
It was Owsley and Fiala (1997) who 
suggested moving the malar fat pad craniolaterally to 
improve nasolabial folds [25]. However, surgery often 
is not necessary since soft tissue filler injections the 
malar fat pad can volumize this compartment resulting 
in smoothed nasolabial folds and younger appearance 
[26, 27]. 
The most versatile and popular filler 
nowadays is HA. Since native HA becomes rapidly 
decomposed by endogenous hyaluronidase, HA filler 
uses various cross-linking technologies to increase 
durability. HA fillers are of high-molecular weight [28]. 
Histologic investigations demonstrated filler deposits 
mainly within the subcutaneous tissue. Thus the term 
„dermal filler“ is a misnomer [29]. Activation of dermal 
fibroblasts has been claimed for HA fillers. Recently, 
this has been questioned [30]. Instead, a spatial 
modification of facial fat tissue and activation of 
adipose tissue derived stem cells has been suggested 
[31]. 
 
Figure 3: Perinasal fat pad of large mature adipocytes with a more 
densely connective tissue network representing type 2 sWAT or 
fibrous type fat pad 
 
 
By detailed investigations – both with imaging 
techniques and cadaveric studies – of deep midfacial 
fat pads, it became evident that for volumizing one 
should specifically target these structures. Deep 
medial cheek fat pads and sup-orbicularis oculi fat 
pads of layer 4 of soft facial tissue are crucial in 
midfacial rejuvenation and are used to correct the 
cheek sagging which is a major aggravating factor for 
deep nasolabial folds [11, 24]. 
De Maio addressed this point and added two 
structural support depots of the lateral midface, i.e. 
zygomatic arch and zygomatic prominence, for 
optimal cheek rejuvenation [11]. 
For longevity of filler effects, however, the 
deep midfacial fat pads are of outmost importance 
(Fig. 4). 
Cadaveric studies from Wan et al. (2014) 
argue for differences in superficial and deep facial fat 
pads. Indeed, they observed that the average 
adipocyte size of deep medial cheek fat was 
significantly smaller than that of nasolabial fat (p < 
0.0001) [32]. Small adipocytes have a diameter of 
about 40 µm. The Smaller size is connected to 
alterations of fatty acid composition [33]. 
 
Figure 4: Filler deposition (blueish) along the suborbicularis oculi fat 
(SOOF) and in the deep medial fat pad 
 
 
Collagen VI is one of the most abundant 
collagens in adipose tissue and consists of three 
isoforms. COL6A3 isoform has previously been 
implicated in fibrosis [34]. COL6A3 mRNA expression 
is 2.8-fold higher in small compared to large 
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adipocytes (P = 0.004) [35]. Low-molecular HA cannot 
only stimulate fibrosis but support assembly of 
collagen IV [6]. Both factors may contribute to an 
improved mechanical stiffness after HA filler 
injections. 
 
 
Hyaluronic acid and adipose tissue-
derived stem cells 
 
There is evidence that HA may support 
human adipose tissue derived stem cells (ASCs). 
Using the in vivo model of nude mice, HA gel 
containing ASCs was subcutaneously injected into the 
subcutaneous pocket in the back. Eight weeks after 
injection, ASCs were well attached to and proliferated 
on the HA gel. By this time new adipose tissue 
developed. Analysis of neo-adipose tissues by PCR 
revealed the presence of the Alu gene, repetitive 
elements of the human genome [36]. 
In a vocal fold injury model of Sprague-
Dawley rates, local injection of ASC (ASC group) was 
as effective as bone marrow-derived stem cells 
(BMSC group). Histological examination showed 
significantly increased hyaluronic acid (HA) and 
decreased dense collagen deposition. Real-time PCR 
revealed that hyaluronan synthase 1 (Has1) and Has2 
were upregulated in the ASC group. Fibroblast growth 
factor 2 (basic), hepatocyte growth factor and Has3 
were upregulated in both cell transplantation groups 
[37]. Interestingly, smaller scaffolds (diameter about 
40 µm) produced more ADSs cells than larger ones 
[38]. 
ASCs express the HA receptor CD44 [39-41]. 
Proliferation among ADSs occurs almost exclusively 
in those who express CD44 [42]. 
These findings might have a consequence for 
facial rejuvenation with HA fillers. Injection of HA fillers 
deep in the facial fat pads could be a stimulator of 
ASC expansion and differentiation leading to adipose 
tissue hyperplasia. When the injected fillers become 
degraded, low-molecular weight HA may support the 
3D-connective tissue network. Adipose tissue 
hyperplasia is more important for volumizing whereas 
stimulated extracellular connective fibre network can 
contribute to mechanical stiffness [6, 43]. 
Such a view might explain the clinical 
observation, which HA fillers provide a significantly 
longer durability in improving nasolabial folds 
compared to collagen fillers [44-48]. 
HA filler injection in more superficial fat 
compartments - as in lip enhancement or for perioral 
rejuvenation - has a more limited effect on mechanical 
properties, volume preservation and durability [49, 
50]. The less intense stimulation of deep seated ADS 
may be an important underlying factor. 
In conclusion, the findings discussed argue 
for HA fillers as stimulators of ADCs with a 
pronounced effect and considerable duration of 
beautification when injected into the deep midfacial fat 
pads [31]. Future direction in filler development should 
aim to specifically induce and control expansion and 
differentiation of ADCs in deep dermal fat pads, 
thereby aiming a durability obtained today only in case 
of successful adipose tissue transfer [51, 52]. 
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